Effect of probiotics on allergic rhinitis in Df, Dp or dust-sensitive children: a randomized double blind controlled

Teng-Yi Lin1, Chia-Jung Chen, Li-Kuang Chen

  • 1Department of Laboratory Medicine, Buddhist Tzu Chi General Hospital, Hualien, Taiwan.

Indian Pediatrics
|June 26, 2012
PubMed

Insights

Lactobacillus salivarius supplementation effectively reduced allergic rhinitis symptoms and medication use in children. This probiotic intervention showed significant clinical benefits without altering immunological markers.

Area of Science:

  • Immunology
  • Microbiology
  • Pediatrics

Background:

  • Allergic rhinitis (AR) significantly impacts children's quality of life.
  • Current treatments for AR may have limitations or side effects.
  • Probiotics, like Lactobacillus salivarius, are being explored for immune modulation.

Purpose of the Study:

  • To investigate the efficacy of Lactobacillus salivarius in managing allergic rhinitis symptoms in children.
  • To assess the impact of Lactobacillus salivarius on medication requirements for allergic rhinitis.

Main Methods:

  • A double-blind, randomized, controlled trial was conducted.
  • Children with allergic rhinitis received daily Lactobacillus salivarius or a placebo for 12 weeks.
  • Rhinitis symptom and medication scores were assessed regularly, alongside immunological and blood cell counts.

Main Results:

  • Lactobacillus salivarius treatment led to a significant reduction in rhinitis symptoms.
  • A notable decrease in medication scores was observed in the probiotic group.
  • No significant differences in immunological or blood cell variables were found between groups.

Conclusions:

  • Lactobacillus salivarius is a promising therapeutic option for reducing allergic rhinitis symptoms in children.
  • This probiotic may decrease the need for medication in pediatric allergic rhinitis.
  • Further research could explore mechanisms and long-term effects.
Abstract

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions02:06

Allergic Reactions

Overview
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...